Benzinga | Feb 18, 2021 12:09PM EST

HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $11

HC Wainwright & Co. analyst Joseph Pantginis maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target from $8 to $11.